BVXV Annual Total Long Term Liabilities
$26.49 M
-$2.12 M-7.41%
31 December 2022
Summary:
As of February 3, 2025, BVXV annual total long term liabilities is $26.49 million, with the most recent change of -$2.12 million (-7.41%) on December 31, 2022. During the last 3 years, it has fallen by -$20.25 million (-43.32%).BVXV Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Quarterly Long Term Liabilities
$25.12 M
-$402.00 K-1.58%
30 June 2023
Summary:
As of February 3, 2025, BVXV quarterly total long term liabilities is $25.12 million, with the most recent change of -$402.00 thousand (-1.58%) on June 30, 2023. Over the past year, it has increased by +$8.54 million (+51.47%).BVXV Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.4% | +51.5% |
| 3 y3 years | -43.3% | -38.7% |
| 5 y5 years | +396.0% | +118.5% |
BVXV Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -43.3% | -46.3% |
BiondVax Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $25.12 M(-1.6%) |
| Mar 2023 | - | $25.52 M(-3.6%) |
| Dec 2022 | $26.49 M(-7.4%) | $26.49 M(+57.1%) |
| Sept 2022 | - | $16.87 M(+1.7%) |
| June 2022 | - | $16.59 M(-25.6%) |
| Mar 2022 | - | $22.28 M(-22.1%) |
| Dec 2021 | $28.61 M(+1157.1%) | $28.61 M(+1302.7%) |
| Sept 2021 | - | $2.04 M(-8.7%) |
| June 2021 | - | $2.24 M(+3.5%) |
| Mar 2021 | - | $2.16 M(-5.1%) |
| Dec 2020 | $2.28 M(-95.1%) | $2.28 M(-88.0%) |
| Sept 2020 | - | $19.02 M(-53.6%) |
| June 2020 | - | $40.98 M(+1.4%) |
| Mar 2020 | - | $40.43 M(-13.5%) |
| Dec 2019 | $46.74 M(+52.7%) | $46.74 M(+19.1%) |
| Sept 2019 | - | $39.24 M(+1.4%) |
| June 2019 | - | $38.69 M(+24.5%) |
| Mar 2019 | - | $31.08 M(+1.6%) |
| Dec 2018 | $30.60 M | $30.60 M(+74.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $17.59 M(+53.0%) |
| June 2018 | - | $11.50 M(+95.5%) |
| Mar 2018 | - | $5.88 M(+10.1%) |
| Dec 2017 | $5.34 M(+558.6%) | $5.34 M(+58.3%) |
| Sept 2017 | - | $3.37 M(-35.7%) |
| June 2017 | - | $5.25 M(+74.1%) |
| Mar 2017 | - | $3.01 M(+271.8%) |
| Dec 2016 | $810.80 K(-47.8%) | $810.80 K(-15.5%) |
| Sept 2016 | - | $959.40 K(-25.9%) |
| June 2016 | - | $1.30 M(+6.2%) |
| Mar 2016 | - | $1.22 M(-21.5%) |
| Dec 2015 | $1.55 M(+9668.6%) | $1.55 M(-11.9%) |
| Sept 2015 | - | $1.76 M(-16.9%) |
| June 2015 | - | $2.12 M(>+9900.0%) |
| Mar 2015 | - | $16.20 K(+1.9%) |
| Dec 2014 | $15.90 K(+0.6%) | $15.90 K(-4.2%) |
| Sept 2014 | - | $16.60 K(+5.1%) |
| Dec 2013 | $15.80 K(+23.4%) | $15.80 K |
| Dec 2012 | $12.80 K | - |
FAQ
- What is BiondVax Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual total long term liabilities year-on-year change?
- What is BiondVax Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly long term liabilities year-on-year change?
What is BiondVax Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of BVXV is $26.49 M
What is the all time high annual total long term liabilities for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual total long term liabilities is $46.74 M
What is BiondVax Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, BVXV annual total long term liabilities has changed by -$2.12 M (-7.41%)
What is BiondVax Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of BVXV is $25.12 M
What is the all time high quarterly long term liabilities for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly total long term liabilities is $46.74 M
What is BiondVax Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, BVXV quarterly total long term liabilities has changed by +$8.54 M (+51.47%)